NCT05822037 CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia Status RECRUITING Phase NA
NCT05820763 Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant Status WITHDRAWN Phase PHASE2
NCT05804032 Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT05802992 The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients Status UNKNOWN Phase PHASE3
NCT05789303 Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05786105 Optical Genome Mapping in Characterization of Multiple Myeloma Status COMPLETED Phase N/A
NCT05776979 Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients Status RECRUITING Phase PHASE2
NCT05775094 A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05768178 DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. Status RECRUITING Phase PHASE2/PHASE3
NCT05767359 CAR- PRISM (PRecision Intervention Smoldering Myeloma) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05740891 AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma Status UNKNOWN Phase PHASE1
NCT05724966 Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma Status COMPLETED Phase N/A
NCT05722405 Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma Status RECRUITING Phase PHASE4
NCT05718401 The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics Status UNKNOWN Phase N/A
NCT05714839 A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments Status RECRUITING Phase PHASE1/PHASE2
NCT05712967 Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression Status COMPLETED Phase N/A
NCT05712083 A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT05706766 Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Status RECRUITING Phase NA